Proteomics

Dataset Information

0

Urinary proteomics investigations into contrast-induced acute kidney injury


ABSTRACT: The incidence of CI-AKI varies from 5% to 20% among hospitalized patients. However, research on the pathophysiological mechanism and biomarkers of CI-AKI has not been deep so far, especially research with LC-MS/MS methods. MS has brought proteomics research into the modern era and continues to be the best choice for accurate medicine. Thus, we identified the urine proteins of CI-AKI patients with LC-MS/MS methods and compared the differences in urine protein expression between CI-AKI patients and non-CI-AKI patients with bioinformatics analysis. Several DEPs were identified in CI-AKI patients, some of which are related to kidney diseases, including annexin A2 (ANXA2), growth differentiation factor 15 (GDF15) and retinol-binding protein 4 (RBP4). We think that they are likely to be biomarkers of CI-AKI. Among the DEPs, we found that the number and degree of proteins expressed in tubules were more significant than those in glomeruli, which indicated that tubule injury may play a more important role in CI-AKI. Through bioinformatics analysis, we found that the immune response and inflammation were involved in CI-AKI, which indicated that the immune system and inflammatory response may participate in CI-AKI progression. Our study revealed some proteins that are likely to be biomarkers and provided a further understanding of CI-AKI.

ORGANISM(S): Homo Sapiens

SUBMITTER: Shuai Han  

PROVIDER: PXD024271 | iProX | Sun Feb 21 00:00:00 GMT 2021

REPOSITORIES: iProX

altmetric image

Publications

Urinary proteomics investigations into contrast-induced acute kidney injury.

Zhu Hong H   Chu Wenwen W   Han Shuai S   Gao Bihu B   Wang Xin X  

PloS one 20211020 10


Some patients have a decline in renal function after contrast medium injection, and this phenomenon is called contrast-induced acute kidney injury (CI-AKI); a small number of people even suffer severe renal failure. To date, the mechanism of CI-AKI remains unclear. We aimed to identify novel potential biomarkers in the urine of patients with CI-AKI through LC-MS/MS and bioinformatics analysis. We enrolled patients who underwent coronary angiography (contrast agent: iohexol). The CI-AKI group inc  ...[more]

Similar Datasets

2016-05-14 | E-GEOD-81400 | biostudies-arrayexpress
2022-02-26 | GSE197272 | GEO
2016-05-14 | GSE81400 | GEO
2017-05-31 | MSV000081129 | MassIVE
2020-04-10 | GSE130796 | GEO
2020-04-10 | GSE130795 | GEO
2024-08-01 | GSE266436 | GEO
2023-11-17 | GSE248078 | GEO
2022-08-24 | GSE199321 | GEO
2025-02-18 | GSE282344 | GEO